Wed, Jul 22 08:20 PM

Curis, Inc. (CRIS) Discusses Positive Data From Emavusertib Combination Study in Primary CNS Lymphoma Transcript

Seeking Alpha•Wed, Jul 22, 2026, 05:50 PM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Seeking Alpha](https://seekingalpha.com/article/4924335-curis-inc-cris-discusses-positive-data-from-emavusertib-combination-study-in-primary-cns?source=feed_all_articles)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Seeking Alpha ↗

#finance #curis #inc #cris #discusses #positive #data #emavusertib #combination

More Headlines

FinanceMarketWatch• 7m ago

The Treasury market touches a worrying milestone not seen since 2007

There are a host of challenges at work as the ‘long’ 30-year Treasury yield logs its longest stretch above 5% in 19 years

FinanceSeeking Alpha• 10m ago

NovaGold Resources Inc. (NG:CA) M&A Call Transcript

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 10m ago

Weatherford International plc (WFRD) Q2 2026 Earnings Call Transcript

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 10m ago

Alstom SA (ALSMY) Q1 2027 Sales/Trading Call Transcript

Developing story — details emerging. Check the source link for the latest updates.

FinanceCNBC• 10m ago

U.S. Secret Service official: 'Threat environment is the highest we've ever seen'

The Secret Service has seen a 40% increase this year in cases involving threats to protectees, including President Donald Trump.

FinanceSeeking Alpha• 15m ago

OpenAI's Rogue AI Threatens The Whole Market

Developing story — details emerging. Check the source link for the latest updates.